Increased plasma basic fibroblast growth factor is associated with coronary heart disease in adult type 2 diabetes mellitus.

[1]  入江 潤一郎,et al.  Glucose control and vascular complications in veterans with type 2 diabetes , 2009 .

[2]  R. Goldberg.  Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications. , 2009, The Journal of clinical endocrinology and metabolism.

[3]  Robert J. Anderson,et al.  Plasma basic fibroblast growth factor is correlated with plasminogen activator inhibitor-1 concentration in adults from the Veterans Affairs Diabetes Trial. , 2008, Metabolism: clinical and experimental.

[4]  倉田 晃文.  Blockade of Angiotensin II type-1 receptor reduces oxidative stress in adipose tissue and ameliorates adipocytokine dysregulation , 2008 .

[5]  A. Cucina,et al.  High density lipoproteins downregulate basic fibroblast growth factor production and release in minimally oxidated-LDL treated smooth muscle cells. , 2006, Atherosclerosis.

[6]  Michael M. Engelgau,et al.  Prevalence of Diabetes and Impaired Fasting Glucose in Adults in the U.S. Population , 2006, Diabetes Care.

[7]  S. Wild,et al.  Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. , 2004, Diabetes care.

[8]  D. Reda,et al.  Design of the cooperative study on glycemic control and complications in diabetes mellitus type 2: Veterans Affairs Diabetes Trial. , 2003, Journal of diabetes and its complications.

[9]  J. Pankow,et al.  Prediction of coronary heart disease in middle-aged adults with diabetes. , 2003, Diabetes care.

[10]  B. Sobel,et al.  Induction of Plasminogen Activator Inhibitor-1 in Endothelial Cells by Basic Fibroblast Growth Factor and Its Modulation by Fibric Acid , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[11]  M. Zimering.  Effect of intravenous bisphosphonates on release of basic fibroblast growth factor in serum of patients with cancer-associated hypercalcemia. , 2002, Life sciences.

[12]  M. Majima,et al.  Effect of neutral endopeptidase inhibitor on bradykinin-induced bronchoconstriction. , 2001, Life sciences.

[13]  R. Klein,et al.  The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus. , 2000, Archives of internal medicine.

[14]  J. Michel,et al.  Shear stress induces angiotensin converting enzyme expression in cultured smooth muscle cells: possible involvement of bFGF. , 2000, Cardiovascular research.

[15]  P. Ray,et al.  Basic fibroblast growth factor in HIV-associated hemolytic uremic syndrome , 1999, Pediatric Nephrology.

[16]  L. Devi,et al.  Inflammatory Mediators Regulate Cathepsin S in Macrophages and Microglia: A Role in Attenuating Heparan Sulfate Interactions , 1999, Molecular medicine.

[17]  L. Weinehall,et al.  High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor. , 1998, Circulation.

[18]  J. Kral,et al.  Differences in prostate and adipose tissue basic fibroblast growth factor: analysis of preliminary results. , 1997, Urology.

[19]  M. Eldar,et al.  Serum basic fibroblast growth factor levels in patients with ischemic heart disease. , 1997, International journal of cardiology.

[20]  J. Pickering,et al.  Coordinated effects of fibroblast growth factor-2 on expression of fibrillar collagens, matrix metalloproteinases, and tissue inhibitors of matrix metalloproteinases by human vascular smooth muscle cells. Evidence for repressed collagen production and activated degradative capacity. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[21]  R. Gallo,et al.  Inflammatory cytokines induce endothelial cells to produce and release basic fibroblast growth factor and to promote Kaposi's sarcoma-like lesions in nude mice. , 1997, Journal of immunology.

[22]  J. Eng,et al.  Increased basic fibroblast growth factor-like substance in plasma from a subset of middle-aged or elderly male diabetic patients with microalbuminuria or proteinuria. , 1996, The Journal of clinical endocrinology and metabolism.

[23]  S. Hughes.  Localisation and differential expression of the fibroblast growth factor receptor (FGFR) multigene family in normal and atherosclerotic human arteries. , 1996, Cardiovascular research.

[24]  K. Sharma,et al.  Hyperglycemia and Diabetic Kidney Disease: The Case for Transforming Growth Factor–β as a Key Mediator , 1995, Diabetes.

[25]  D. Crossman,et al.  Expression of basic and acidic fibroblast growth factors and their receptor in normal and atherosclerotic human arteries. , 1993, Cardiovascular Research.

[26]  H. Itoh,et al.  Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II. , 1993, The Journal of clinical investigation.

[27]  D. Hajjar,et al.  Induction of basic fibroblast growth factor mRNA and protein synthesis in smooth muscle cells by cholesteryl ester enrichment and 25-hydroxycholesterol. , 1993, The Journal of biological chemistry.

[28]  J. Neaton,et al.  Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial , 1993, Diabetes Care.

[29]  M. Deitel,et al.  Augmented production of heparin-binding mitogenic proteins by preadipocytes from massively obese persons. , 1992, The Journal of clinical investigation.

[30]  R. Hamanaka,et al.  Endogenous basic fibroblast growth factor-dependent induction of collagenase and interleukin-6 in tumor necrosis factor-treated human microvascular endothelial cells. , 1991, The Journal of biological chemistry.

[31]  M. Reidy,et al.  Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[32]  D. Rifkin,et al.  The stimulatory effect of PDGF on vascular smooth muscle cell migration is mediated by the induction of endogenous basic FGF. , 1991, Biochemical and biophysical research communications.

[33]  K. Borch-Johnsen,et al.  Albuminuria reflects widespread vascular damage , 1989, Diabetologia.

[34]  D. Gospodarowicz,et al.  Structural characterization and biological functions of fibroblast growth factor. , 1987, Endocrine reviews.

[35]  J. Fiddes,et al.  Capillary endothelial cells express basic fibroblast growth factor, a mitogen that promotes their own growth , 1987, Nature.

[36]  N. Ling,et al.  Primary structure of bovine pituitary basic fibroblast growth factor (FGF) and comparison with the amino-terminal sequence of bovine brain acidic FGF. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[37]  A. Larsson,et al.  Serum and plasma levels of FGF-2 and VEGF in healthy blood donors , 2004, Angiogenesis.

[38]  L. Hansson,et al.  High sensitivity CRP and serum amyloid A as expressions of low grade inflammation do not correlate with bFGF or VEGF. , 2003, Upsala journal of medical sciences.

[39]  P. Vermeulen,et al.  Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients. , 1997, British Journal of Cancer.